Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

被引：12
|
作者：
Romaguera, Jorge E. [1 ]
Lee, Hun J. [1 ]
Tarapore, Rohinton [3 ]
Prabhu, Varun [3 ]
Allen, Joshua [3 ]
Schalop, Lee [1 ]
Zloza, Andrew [2 ]
Ok, Chi Y. [4 ]
Sadimin, Evita T. [5 ]
Schenkel, Jason [6 ]
Badillo, Maria [1 ]
Wang, Michael [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[3] Oncoceutics Inc, Philadelphia, PA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[5] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ USA
[6] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 01期
关键词：
mantle cell lymphoma; ONC201; Ibrutinib-refractory;
D O I：
10.1111/bjh.15271
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 136
页数：4
相关论文
共 50 条
  • [1] Integrated Stress Response and Immune Cell Infiltration in an Ibrutinib-Refractory Mantle Cell Lymphoma Patient Following ONC201 Treatment
    Romaguera, Jorge Enrique
    Lee, Hun Ju
    Tarapore, Rohinton
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Schalop, Lee
    Zloza, Andrew
    Ok, Chi Young
    Badillo, Maria
    Wang, Michael
    BLOOD, 2017, 130
  • [2] ONC201 Induces Apoptosis in Cutaneous T-Cell Lymphoma Cells through a Mechanism That Involves the Integrated Stress Response and Inactivation of Jak/Stat Signaling
    Duvic, Madeleine
    Zhang, Xiang
    Ni, Xiao
    Langridge, Timothy
    Tarapore, Rohinton
    Allen, Josh
    BLOOD, 2015, 126 (23)
  • [3] SIMULATION MODEL OF IBRUTINIB IN TREATMENT OF RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL)
    Peng, S.
    Sorensen, S.
    Pan, F.
    Dorman, E.
    Sun, S.
    Van Sanden, S.
    Sengupta, N.
    Gaudig, M.
    VALUE IN HEALTH, 2014, 17 (07) : A620 - A620
  • [4] The integrated stress response (ISR) is involved in the synergistic combinatorial efficacy of ONC201 and epigenetic modulators in brain tumor cell lines.
    Zhang, Yiqun
    Zhou, Lanlan
    Prabhu, Varun V.
    Allen, Joshua E.
    Seyhan, Attila A.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma
    Locke, Clifford B., Jr.
    Lansigan, Frederick
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [6] Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib
    Panagiotis T. Diamantopoulos
    Mina Psichogiou
    Angeliki Pantazatou
    Konstantinos Zervakis
    Niki Rougala
    Nefeli Giannakopoulou
    George Daikos
    Nora-Athina Viniou
    Annals of Hematology, 2017, 96 : 1049 - 1050
  • [7] Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib
    Diamantopoulos, Panagiotis T.
    Psichogiou, Mina
    Pantazatou, Angeliki
    Zervakis, Konstantinos
    Rougala, Niki
    Giannakopoulou, Nefeli
    Daikos, George
    Viniou, Nora-Athina
    ANNALS OF HEMATOLOGY, 2017, 96 (06) : 1049 - 1050
  • [8] ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
    Carlos, F.
    Herrera, M.
    Salazar, A.
    Aguirre, A.
    Gonzalez-Michaca, L.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
  • [9] Ibrutinib and rituximab association: interest of a chemotherapy free treatment in relapsed or refractory mantle cell lymphoma
    Philippe, Laure
    HEMATOLOGIE, 2016, 22 (01): : 12 - 13
  • [10] IBRUTINIB PLUS WITH VENETOCLAX FOR THE TREATMENT OF PRIMARY REFRACTORY MANTLE-CELL LYMPHOMA: A REAL LIFE EXPERIENCE
    Fabbri, A.
    Cencini, E.
    Congiu, A. G.
    Miglino, M.
    Rigacci, L.
    Bocchia, M.
    HAEMATOLOGICA, 2019, 104 : 161 - 161
12345